<p>In this episode of Lab to Startup, I speak with Brian Feth and James Lim, co-founders of XCellBio. We explore the startup story and learn about:</p> <ul> <li>The founding story- the initial hypothesis behind the product they wanted to build and how the technology evolved since then based on customer feedback</li> <li>Fundraising trials and tribulations</li> <li>How there was a lesson hidden in every “No” they received from potential customers and investors</li> <li>Role that partnerships played</li> <li>Traits like flexibility, open communication and co-founder chemistry  Learn more about XCell Biosciences: <a href= "https://www.xcellbio.com">https://www.xcellbio.com</a></li> </ul>

In this episode of Lab to Startup, I speak with Brian Feth and James Lim, co-founders of XCellBio. We explore the startup story and learn about: The founding story- the initial hypothesis behind the product they wanted to build and how the technology evolved since then based on customer feedback Fundraising trials and tribulations How there was a lesson hidden in every “No” they received from potential customers and investors Role that partnerships played Traits like flexibility, open communication and co-founder chemistry Learn more about XCell Biosciences: https://www.xcellbio.com

<p>In this episode of Lab to Startup, I speak with Brian Feth and James Lim, co-founders of XCellBio. We explore the startup story and learn about:</p> <ul> <li>The founding story- the initial hypothesis behind the product they wanted to build and how the technology evolved since then based on customer feedback</li> <li>Fundraising trials and tribulations</li> <li>How there was a lesson hidden in every “No” they received from potential customers and investors</li> <li>Role that partnerships played</li> <li>Traits like flexibility, open communication and co-founder chemistry  Learn more about XCell Biosciences: <a href="https://www.xcellbio.com" rel="noopener noreferrer">https://www.xcellbio.com</a></li> </ul>

XCell Biosciences - Cell culturing technology to enhance drug screening and the performance of cell therapies

Hundreds of thousands of researchers around the world are working to improve life and address imminent threats to humanity. Often, the research ends up in the “Scientific valley of death” in the form of publications and patents that never see the light of the day.

Welcome to “Lab to Startup” a podcast aimed at showcasing the effort needed to translate lab research to startups. The show has two main goals:  1. Sharing the stories of those scientists and engineers who have successfully founded startups based on the research at university and national labs.  2. Highlighting the resources and tools needed to help those aspiring to launch startups in the deeptech space.

We also want this show to be a way to communicate those technology development stories to the general public (taxpayers funding the research) in the hope that they will continue to support such research and startups.

About the host
Naresh Sunkara, Ph.D. is a chemical biologist, entrepreneur and the founder and Executive Director of the Berkeley Postdoc Entrepreneurship Program at the University of California, Berkeley. He has been running this program for the past ten years that has helped graduate students and postdocs at UC Berkeley and Lawrence Berkeley National Laboratory, and at several other universities in the US.

He was previously a postdoc at UC Berkeley developing lipid nanoparticles for delivery of mRNA based drugs targeting viruses and cancers.

Business

Entrepreneurship

Technology

Hundreds of thousands of researchers around the world are working to improve life and address imminent threats to humanity. Often, the research ends up in the “Scientific valley of death” in the form of publications and patents that never see the light of the day. Welcome to “Lab to Startup” a podcast aimed at showcasing the effort needed to translate lab research to startups. The show has two main goals: 1. Sharing the stories of those scientists and engineers who have successfully founded startups based on the research at university and national labs. 2. Highlighting the resources and tools needed to help those aspiring to launch startups in the deeptech space. We also want this show to be a way to communicate those technology development stories to the general public (taxpayers funding the research) in the hope that they will continue to support such research and startups. About the host Naresh Sunkara, Ph.D. is a chemical biologist, entrepreneur and the founder and Executive Director of the Berkeley Postdoc Entrepreneurship Program at the University of California, Berkeley. He has been running this program for the past ten years that has helped graduate students and postdocs at UC Berkeley and Lawrence Berkeley National Laboratory, and at several other universities in the US. He was previously a postdoc at UC Berkeley developing lipid nanoparticles for delivery of mRNA based drugs targeting viruses and cancers.

Hundreds of thousands of researchers around the world are working to improve life and address imminent threats to humanity. Often, the research ends up in the “Scientific valley of death” in the form of publications and patents that never see the light of the day.

Welcome to “Lab to Startup” a podcast aimed at showcasing the effort needed to translate lab research to startups. The show has two main goals:&nbsp; 1. Sharing the stories of those scientists and engineers who have successfully founded startups based on the research at university and national labs.&nbsp; 2. Highlighting the resources and tools needed to help those aspiring to launch startups in the deeptech space.

We also want this show to be a way to communicate those technology development stories to the general public (taxpayers funding the research) in the hope that they will continue to support such research and startups.

About the host
Naresh Sunkara, Ph.D. is a chemical biologist, entrepreneur and the founder and Executive Director of the Berkeley Postdoc Entrepreneurship Program at the University of California, Berkeley. He has been running this program for the past ten years that has helped graduate students and postdocs at UC Berkeley and Lawrence Berkeley National Laboratory, and at several other universities in the US.

He was previously a postdoc at UC Berkeley developing lipid nanoparticles for delivery of mRNA based drugs targeting viruses and cancers.

Share XCell Biosciences - Cell culturing technology to enhance drug screening and the performance of cell therapies

Sign up to save your podcasts

XCell Biosciences - Cell culturing technology to enhance drug screening and the performance of cell therapies

XCell Biosciences - Cell culturing technology to enhance drug screening and the performance of cell therapies

More shows like Lab to Startup

Wait Wait... Don't Tell Me!

WSJ What’s News

The McKinsey Podcast

Freakonomics Radio

Up First from NPR

Conan O’Brien Needs A Friend

The Journal.

All-In with Chamath, Jason, Sacks & Friedberg